Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Prop

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
American Journal of Respiratory and Critical Care Medicine|October 1, 1995
Defective bronchus-associated lymphoid tissue in long-term surviving rat lung allograftsJ B Winter, J Prop, M Groen, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 1, 1996
Clotting and fibrinolytic disturbance during lung transplantation: effect of low-dose aprotinin. Groningen Lung Transplant GroupY J Gu, J de Haan, U P Brenken, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1987
Representativity of human mammary tumor cell cultures: DNA-cytophotometry as a method for checking tumour cell characteristicsJ A Stolwijk, F J Prop, L Eijgenstein, et al.
Transplantation|June 3, 2000
Activation of alloreactive T cells by allogeneic nonprofessional antigen-presenting cells and interleukin-12 from bystander autologous professional antigen-presenting cellsA de Haan, I van der Gun, E van Dijk, et al.
Clinical and Diagnostic Laboratory Immunology|March 1, 1995
Humoral immune response against human cytomegalovirus (HCMV)-specific proteins after HCMV infection in lung transplantation as detected with recombinant and naturally occurring proteinsJ van Zanten, M C Harmsen, M van der Giessen, et al.
Transplantation|May 8, 2000
Decreased donor-specific cytotoxic T cell precursor frequencies one year after clinical lung transplantation do not reflect transplantation tolerance: a comparison of lung transplant recipients with or without bronchiolitis obliterans syndromeA de Haan, I van der Gun, B G Hepkema, et al.
American Journal of Respiratory and Critical Care Medicine|September 3, 1999
Antimyeloperoxidase-associated lung disease. An experimental modelP Foucher, P Heeringa, A H Petersen, et al.
The Journal of Heart Transplantation|March 1, 1988
Antigen test for early diagnosis of active cytomegalovirus infection in heart transplant recipientsW van der Bij, R B van Dijk, W J van Son, et al.
The Journal of Infectious Diseases|September 1, 1995
Proliferative T cell responses to four human cytomegalovirus-specific proteins in healthy subjects and solid organ transplant recipientsJ van Zanten, M C Harmsen, P van der Meer, et al.
Transplantation|September 12, 1998
Donor-specific hyporeactivity after liver transplantation: prominent decreases in donor-specific cytotoxic T lymphocyte precursor frequencies independent of changes in helper T lymphocyte precursor frequencies or suppressor cell activityA de Haan, A P van den Berg, B G Hepkema, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
American Journal of Respiratory and Critical Care Medicine|October 1, 1995
Defective bronchus-associated lymphoid tissue in long-term surviving rat lung allograftsJ B Winter, J Prop, M Groen, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 1, 1996
Clotting and fibrinolytic disturbance during lung transplantation: effect of low-dose aprotinin. Groningen Lung Transplant GroupY J Gu, J de Haan, U P Brenken, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1987
Representativity of human mammary tumor cell cultures: DNA-cytophotometry as a method for checking tumour cell characteristicsJ A Stolwijk, F J Prop, L Eijgenstein, et al.
Transplantation|June 3, 2000
Activation of alloreactive T cells by allogeneic nonprofessional antigen-presenting cells and interleukin-12 from bystander autologous professional antigen-presenting cellsA de Haan, I van der Gun, E van Dijk, et al.
Clinical and Diagnostic Laboratory Immunology|March 1, 1995
Humoral immune response against human cytomegalovirus (HCMV)-specific proteins after HCMV infection in lung transplantation as detected with recombinant and naturally occurring proteinsJ van Zanten, M C Harmsen, M van der Giessen, et al.
Transplantation|May 8, 2000
Decreased donor-specific cytotoxic T cell precursor frequencies one year after clinical lung transplantation do not reflect transplantation tolerance: a comparison of lung transplant recipients with or without bronchiolitis obliterans syndromeA de Haan, I van der Gun, B G Hepkema, et al.
American Journal of Respiratory and Critical Care Medicine|September 3, 1999
Antimyeloperoxidase-associated lung disease. An experimental modelP Foucher, P Heeringa, A H Petersen, et al.
The Journal of Heart Transplantation|March 1, 1988
Antigen test for early diagnosis of active cytomegalovirus infection in heart transplant recipientsW van der Bij, R B van Dijk, W J van Son, et al.
The Journal of Infectious Diseases|September 1, 1995
Proliferative T cell responses to four human cytomegalovirus-specific proteins in healthy subjects and solid organ transplant recipientsJ van Zanten, M C Harmsen, P van der Meer, et al.
Transplantation|September 12, 1998
Donor-specific hyporeactivity after liver transplantation: prominent decreases in donor-specific cytotoxic T lymphocyte precursor frequencies independent of changes in helper T lymphocyte precursor frequencies or suppressor cell activityA de Haan, A P van den Berg, B G Hepkema, et al.
Pageof 6